<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of acute pancreatitis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of acute pancreatitis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Management of acute pancreatitis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Santhi Swaroop Vege, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Douglas G Adler, MD, FACG, AGAF, FASGE</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 26, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Acute pancreatitis is an acute inflammatory process of the pancreas. Mortality ranges from 3 percent in patients with interstitial edematous pancreatitis to 17 percent in patients who develop pancreatic necrosis [<a href="#rid1">1,2</a>].</p><p>This topic reviews the management of acute pancreatitis. Our recommendations are largely consistent with the American Gastroenterological Association, the American College of Gastroenterology, and the International Association of Pancreatology/American Pancreatic Association guidelines for the treatment of acute pancreatitis [<a href="#rid3">3-6</a>]. The etiology, clinical manifestations, diagnosis, and assessment of severity of acute pancreatitis are discussed separately. (See  <a class="medical medical_review" href="/d/html/5640.html" rel="external">"Etiology of acute pancreatitis"</a> and  <a class="medical medical_review" href="/d/html/5652.html" rel="external">"Clinical manifestations and diagnosis of acute pancreatitis"</a> and  <a class="medical medical_review" href="/d/html/5639.html" rel="external">"Predicting the severity of acute pancreatitis"</a>.)</p><p class="headingAnchor" id="H106843438"><span class="h1">CLASSIFICATION</span><span class="headingEndMark"> — </span>According to the Atlanta classification, acute pancreatitis can be divided into two broad categories [<a href="#rid7">7</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Interstitial edematous acute pancreatitis, which is characterized by acute inflammation of the pancreatic parenchyma and peripancreatic tissues, but without recognizable tissue necrosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Necrotizing acute pancreatitis, which is characterized by inflammation associated with pancreatic parenchymal necrosis and/or peripancreatic necrosis.</p><p></p><p>According to the severity, acute pancreatitis is divided into the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Mild acute pancreatitis, which is characterized by the absence of organ failure and local or systemic complications</p><p class="bulletIndent1"><span class="glyph">●</span>Moderately severe acute pancreatitis, which is characterized by no organ failure or transient organ failure (&lt;48 hours) and/or local complications </p><p class="bulletIndent1"><span class="glyph">●</span>Severe acute pancreatitis, which is characterized by persistent organ failure (&gt;48 hours) that may involve one or multiple organs</p><p></p><p class="headingAnchor" id="H446700317"><span class="h1">ASSESSMENT OF DISEASE SEVERITY</span><span class="headingEndMark"> — </span>At initial evaluation, the severity of acute pancreatitis should be assessed by clinical examination to assess for early fluid losses, organ failure (particularly cardiovascular, respiratory, or renal compromise)  (<a class="graphic graphic_table graphicRef87718" href="/d/graphic/87718.html" rel="external">table 1</a>), measurement of the systemic inflammatory response syndrome (SIRS) score  (<a class="graphic graphic_table graphicRef69207" href="/d/graphic/69207.html" rel="external">table 2</a>) [<a href="#rid8">8</a>]. </p><p>We perform the following laboratory tests to help establish the severity of acute pancreatitis and guide management. These include a complete metabolic panel, serum calcium, complete blood count, serum triglycerides and lactate. Although measurement of serum amylase and lipase is useful for diagnosis of pancreatitis, serial measurements in patients with acute pancreatitis are not useful to predict disease severity, prognosis, or for altering management.</p><p>Routine abdominal computed tomography (CT) scan is not recommended at initial presentation in patients with acute pancreatitis unless there is diagnostic uncertainty because there is no evidence that CT improves clinical outcomes and the complete extent of pancreatic and peripancreatic necrosis may only become clear 72 hours after the onset of acute pancreatitis [<a href="#rid4">4</a>]. Several other scoring systems also exist to predict the severity of acute pancreatitis based upon clinical, laboratory, radiologic risk factors, and serum markers but can be used only 24 to 48 hours after disease onset and have not been shown to be consistently superior to assessment of SIRS or the APACHE II score. The assessment of disease severity in acute pancreatitis is discussed in detail, separately. (See  <a class="medical medical_review" href="/d/html/5639.html" rel="external">"Predicting the severity of acute pancreatitis"</a>.)</p><p class="headingAnchor" id="H106843693"><span class="h2">Indications for monitored or intensive care</span><span class="headingEndMark"> — </span>Admission to an intensive care unit setting is indicated in the following patients [<a href="#rid4">4,8,9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with severe acute pancreatitis </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with acute pancreatitis and one or more of the following parameters:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pulse &lt;40 or &gt;150 beats/minute</p><p class="bulletIndent2"><span class="glyph">•</span>Systolic arterial pressure &lt;80 mmHg or mean arterial pressure &lt;60 mmHg or diastolic arterial pressure &gt;120 mmHg</p><p class="bulletIndent2"><span class="glyph">•</span>Respiratory rate &gt;35 breaths/minute</p><p class="bulletIndent2"><span class="glyph">•</span>Serum sodium &lt;110 mmol/L or &gt;170 mmol/L</p><p class="bulletIndent2"><span class="glyph">•</span>Serum potassium &lt;2.0 mmol/L or &gt;7.0 mmol/L</p><p class="bulletIndent2"><span class="glyph">•</span>PaO<sub>2</sub> &lt;50 mmHg</p><p class="bulletIndent2"><span class="glyph">•</span>pH &lt;7.1 or &gt;7.7</p><p class="bulletIndent2"><span class="glyph">•</span>Serum glucose &gt;800 mg/dL</p><p class="bulletIndent2"><span class="glyph">•</span>Serum calcium &gt;15 mg/dL</p><p class="bulletIndent2"><span class="glyph">•</span>Anuria</p><p class="bulletIndent2"><span class="glyph">•</span>Coma</p><p></p><p>In patients with severe acute pancreatitis, intensive care unit monitoring and support of pulmonary, renal, circulatory, and hepatobiliary function may minimize systemic sequelae [<a href="#rid8">8</a>]. Transfer to a monitored or intensive care unit may be considered in the following patients, although it is not uncommon for these patients to be treated on the floor in centers with significant expertise in acute pancreatitis [<a href="#rid10">10</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Persistent (&gt;48 hours) SIRS  (<a class="graphic graphic_table graphicRef69207" href="/d/graphic/69207.html" rel="external">table 2</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated hematocrit (&gt;44 percent), blood urea nitrogen (BUN) (&gt;20 mg/dL), or creatinine (&gt;1.8 mg/dL) </p><p class="bulletIndent1"><span class="glyph">●</span>Age &gt;60 years</p><p class="bulletIndent1"><span class="glyph">●</span>Underlying cardiac or pulmonary disease, obesity</p><p></p><p class="headingAnchor" id="H2"><span class="h1">INITIAL MANAGEMENT</span><span class="headingEndMark"> — </span>Initial management of a patient with acute pancreatitis consists of supportive care with fluid resuscitation, pain control, and nutritional support.</p><p class="headingAnchor" id="H22664712"><span class="h2">Fluid replacement</span><span class="headingEndMark"> — </span>The only effective treatment in the first 24 to 48 hours after the diagnosis of acute pancreatitis is intravenous hydration. Significant third space losses due to inflammatory collections, increased permeability of vasculature resulting in transudation of fluid from intravascular to extravascular compartment, nausea and vomiting and inability to ingest adequate amounts of fluids, lead to increases in hematocrit blood urea nitrogen and creatinine, possible development of necrotizing pancreatic and peripancreatic necrosis and acute kidney injury. Retrospective studies revealed that in the initial stages (within the first 12 to 24 hours) of acute pancreatitis, fluid replacement has been associated with a reduction in morbidity and mortality [<a href="#rid4">4,11-13</a>]. Persistent hemoconcentration at 24 hours has been associated with development of necrotizing pancreatitis [<a href="#rid14">14</a>]. Necrotizing pancreatitis results in vascular leak syndrome leading to increased third space fluid losses and worsening of pancreatic hypoperfusion [<a href="#rid15">15</a>]. </p><p>Despite numerous studies that have evaluated intravenous hydration, the timing, the rate, the type of fluid, the duration of treatment, and the appropriate goal to direct such intravenous hydration is unclear [<a href="#rid16">16</a>]. While previous guidelines have recommended 250 to 500 mL/hour of normal <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> during the first 24 to 48 hours (5 to 10 mL per kilogram of body weight per hour), evidence from randomized controlled trials suggest that a lower volume may be used in patients with mild acute pancreatitis [<a href="#rid3">3,4,17,18</a>]. In a randomized trial, 249 patients with acute pancreatitis were randomly assigned to aggressive fluid resuscitation (<a class="drug drug_general" data-topicid="108196" href="/d/drug information/108196.html" rel="external">lactated Ringer</a>'s solution bolus of 20 mL/kg followed by 3 mL/kg/hour) versus moderate resuscitation (1.5 mL/kg/hour with a 10 mL/kg bolus only in patients with hypovolemia) [<a href="#rid17">17</a>]. In both groups, initial physical assessment was performed at three hours to evaluate for fluid overload, and goal-directed resuscitation was adjusted 12, 24, 48, and 72 hours based on volume status. Although there was no difference in the incidence of moderately severe or severe pancreatitis or duration of hospitalization between the two groups, the trial was terminated early due to higher rates of fluid overload in the aggressive resuscitation group (20 versus 6 percent). </p><p>We use moderate intravenous hydration (1.5 mL/kg/hour with a 10 mL/kg bolus in patients with hypovolemia) with goal-directed therapy for fluid management [<a href="#rid5">5</a>]. Fluid requirements are reassessed at frequent intervals in the first six hours of admission and for the next 24 to 48 hours. The rate of fluid resuscitation is adjusted based on clinical assessment, hematocrit, blood urea nitrogen (BUN), and creatinine values [<a href="#rid19">19</a>]. Adequate fluid replacement can be assessed by an improvement in vital signs (goal heart rate &lt;120 beats/minute, mean arterial pressure between 65 to 85 mmHg), urine output (&gt;0.5 to 1 cc/kg/hour) and reduction in hematocrit (goal 35 to 44 percent) and BUN over 24 hours, particularly if they were high at the onset [<a href="#rid4">4,20</a>]. Monitoring the BUN may be particularly important, as both the BUN at the time of admission and the change in BUN during the first 24 hours of hospitalization predict mortality [<a href="#rid21">21</a>]. Increased fluid resuscitation should be considered in patients whose BUN levels stay the same or increase. It is important to note that a low urine output may reflect the development of acute tubular necrosis rather than persistent volume depletion. In this setting, aggressive fluid replacement can lead to peripheral and pulmonary edema without improving the urine output. (See  <a class="medical medical_review" href="/d/html/7216.html" rel="external">"Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury in adults"</a>.)</p><p>There is conflicting evidence that fluid resuscitation with <a class="drug drug_general" data-topicid="108196" href="/d/drug information/108196.html" rel="external">lactated Ringer</a>'s solution can reduce the incidence of systemic inflammatory response syndrome (SIRS) as compared with normal <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> [<a href="#rid19">19,22-24</a>]. Limited evidence suggests that the use of lactated Ringer's solution in patients with acute pancreatitis may reduce hospital stay and intensive care unit admissions, however, further studies are needed [<a href="#rid24">24</a>]. In rare patients with acute pancreatitis due to hypercalcemia, lactated Ringer's is contraindicated because it contains 3 mEq/L calcium. In these patients, normal saline should be used for volume resuscitation. Several other approaches to fluid replacement have also been reported in patients with acute pancreatitis [<a href="#rid25">25,26</a>]. The use of hydroxyethyl starch containing fluids should be avoided given the absence of demonstrable mortality benefit and possible risk of multiple organ failure [<a href="#rid5">5,27</a>]. (See  <a class="medical medical_review" href="/d/html/14942.html" rel="external">"Intraoperative fluid management", section on 'Hydroxyethyl starches'</a>.)</p><p>It is important to limit fluid resuscitation mainly to the first 24 to 48 hours after onset of the disease. Continued aggressive fluid resuscitation after 48 hours may not be advisable as overly vigorous fluid resuscitation is associated with an increased need for intubation and increased risk of abdominal compartment syndrome.</p><p class="headingAnchor" id="H3"><span class="h2">Pain control</span><span class="headingEndMark"> — </span>Abdominal pain is often the predominant symptom in patients with acute pancreatitis and should be treated with analgesics. Uncontrolled pain can contribute to the hemodynamic instability.</p><p class="bulletIndent1"><span class="glyph">●</span>Attention to adequate fluid resuscitation should be the first priority in addressing abdominal pain, as hypovolemia from vascular leak and hemoconcentration can cause ischemic pain and resultant lactic acidosis. (See <a class="local">'Fluid replacement'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Opioids are safe and effective at providing pain control in patients with acute pancreatitis [<a href="#rid28">28</a>]. Adequate pain control requires the use of intravenous opiates, usually in the form of a patient-controlled analgesia pump. <a class="drug drug_general" data-topicid="8538" href="/d/drug information/8538.html" rel="external">Hydromorphone</a> or <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a> (intravenous) may be used for pain relief in acute pancreatitis. Fentanyl is being increasingly used due to its better safety profile, especially in renal impairment. As with other opiates, fentanyl can depress respiratory function. It can be given both as a bolus as well as constant infusion. The typical dose for the bolus regimen ranges from 20 to 50 micrograms with a 10-minute lock-out period (time from the end of one dose infusion to the time the machine starts responding to another demand). Patients on patient-controlled analgesia should be carefully monitored for side effects. (See  <a class="medical medical_review" href="/d/html/2888.html" rel="external">"Pain control in the critically ill adult patient"</a>.)</p><p></p><p class="bulletIndent1"><a class="drug drug_general" data-topicid="9608" href="/d/drug information/9608.html" rel="external">Meperidine</a> has been favored over <a class="drug drug_general" data-topicid="9788" href="/d/drug information/9788.html" rel="external">morphine</a> for analgesia in pancreatitis because studies showed that morphine caused an increase in sphincter of Oddi pressure. However, there are no clinical studies to suggest that morphine can aggravate or cause pancreatitis or cholecystitis [<a href="#rid29">29</a>]. In addition, meperidine has a short half-life and repeated doses can lead to accumulation of the metabolite normeperidine that causes neuromuscular side effects and, rarely, seizures. </p><p></p><p class="headingAnchor" id="H106843768"><span class="h2">Monitoring</span><span class="headingEndMark"> — </span>Patients with acute pancreatitis should be monitored closely in the first 24 to 48 hours. Patients with organ failure will need ongoing monitoring for other complications that might arise. (See <a class="local">'Management of complications'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span>Vital signs including oxygen saturation should be monitored and supplemental oxygen administered to maintain arterial oxygen saturation of greater than 95 percent. Blood gas analysis should be performed if oxygen saturation is less than 90 percent or if the clinical situation demands. Hypoxia may be due to splinting, atelectasis, pleural effusions, opening of intrapulmonary shunts, or acute respiratory distress syndrome (ARDS). Patients with persistent or progressive hypoxia should be transferred to an intensive care unit (ICU) for ventilatory support. (See  <a class="medical medical_review" href="/d/html/1637.html" rel="external">"Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults"</a> and  <a class="medical medical_review" href="/d/html/1641.html" rel="external">"Acute respiratory distress syndrome: Fluid management, pharmacotherapy, and supportive care in adults"</a> and <a class="local">'Indications for monitored or intensive care'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urine output should be measured hourly and fluids should be titrated to maintain urine output (&gt;0.5 to 1 cc/kg/hour) [<a href="#rid4">4</a>]. (See <a class="local">'Fluid replacement'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Electrolytes should be monitored frequently in the first 48 to 72 hours and especially with aggressive fluid resuscitation. Hypocalcemia should be corrected if ionized calcium is low or if there are signs of neuromuscular irritability (Chvostek's or Trousseau's sign). Low magnesium levels can also cause hypocalcemia and should be corrected. (See  <a class="medical medical_review" href="/d/html/826.html" rel="external">"Treatment of hypocalcemia", section on 'Intravenous calcium dosing'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Serum glucose levels should be monitored hourly in patients with severe pancreatitis and hyperglycemia (blood glucose greater than 180 to 200 mg/dL) should be treated as it can increase the risk of secondary pancreatic infections. Hyperglycemia may result from parenteral nutritional therapy, decreased insulin release, increased gluconeogenesis, and decreased glucose utilization. The management of hyperglycemia is discussed in detail, separately. (See  <a class="medical medical_review" href="/d/html/1600.html" rel="external">"Glycemic control in critically ill adult and pediatric patients", section on 'Our approach'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients in the intensive care unit should be monitored for potential abdominal compartment syndrome with serial measures of urinary bladder pressures [<a href="#rid30">30</a>]. (See <a class="local">'Abdominal compartment syndrome'</a> below.)</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Nutrition</span><span class="headingEndMark"> — </span>Patients with mild pancreatitis can often be managed with intravenous hydration alone since recovery occurs rapidly, allowing patients to resume an oral diet within a week. Nutritional support is often required in patients with moderately severe pancreatitis if they are unlikely to resume oral intake within five to seven days Nasojejunal tube feeding (using an elemental or semi-elemental formula) is preferred to total <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a> (TPN). </p><p class="headingAnchor" id="H34183426"><span class="h3">Oral</span><span class="headingEndMark"> — </span>The time to reinitiate oral feedings depends on the severity of the pancreatitis. (See <a class="local">'Assessment of disease severity'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span>In the absence of ileus, nausea or vomiting, oral feeding can be initiated early (within 24 hours) as tolerated, if the pain is decreasing and inflammatory markers are improving [<a href="#rid4">4-6</a>]. We usually start with a low residue, low fat, soft diet, provided there is no evidence of ileus or significant nausea and/or vomiting. We then advance the diet cautiously as tolerated. Traditionally, patients have been advanced from a clear liquid diet to solid food as tolerated. Early refeeding with a solid, low fat diet when patients are subjectively hungry, regardless of resolution of abdominal pain and normalization of pancreatic enzymes, may be safe [<a href="#rid31">31-35</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In some patients with moderately severe to severe pancreatitis, oral feeding may not be tolerated due to postprandial pain, nausea or vomiting related to gastroduodenal inflammation and/or extrinsic compression from fluid collections leading to gastric outlet obstruction. Such patients require enteral if they cannot tolerate oral diet by day five [<a href="#rid5">5</a>]. However, when the local complications start improving, oral feeds can be initiated and advanced as tolerated. (See <a class="local">'Enteral'</a> below.)</p><p></p><p>In a systematic review of 11 randomized trials that included 948 patients with acute pancreatitis, early refeeding (≤48 after hospitalization), as compared with delayed refeeding, did not increase adverse effects or exacerbate symptoms [<a href="#rid36">36</a>]. In four of seven trials that included patients with mild to moderate pancreatitis, early refeeding was associated with a reduction in length of hospital stay. However, there was significant heterogeneity in feeding protocols and reported outcomes across studies and a high risk of bias in several studies included in the systematic review. Additional randomized trials are needed to define the benefits of early refeeding in patients with acute pancreatitis [<a href="#rid37">37</a>]. However, a multicenter trial comparing enteral nutrition in the first 24 hours with enteral feeding after 72 hours in patients with predicted severe acute pancreatitis did not find any improved clinical outcomes with early enteral feeding [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H5"><span class="h3">Enteral</span><span class="headingEndMark"> — </span>Enteral feeding rather than <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a> is recommended in patients with moderately severe and severe acute pancreatitis who cannot tolerate oral feeding [<a href="#rid3">3,4,39,40</a>]. In patients with predicted severe or necrotizing pancreatitis requiring enteral tube feeding either nasogastric or naso-enteral route may be used. We also initiate enteral feeding when it becomes clear that the patient will not be able to consume nourishment by mouth (eg, transfer to an intensive care unit, development of organ failure, or SIRS persisting for 48 hours). This assessment can usually be made by the fifth day of the illness. (See  <a class="medical medical_review" href="/d/html/1605.html" rel="external">"Nutrition support in intubated critically ill adult patients: Enteral nutrition"</a>.)</p><p>Enteral feeding requires radiologic or endoscopic placement of a jejunal feeding tube beyond the ligament of Treitz. If placement of a nasojejunal feeding tube is not possible, nasogastric feeding should be initiated [<a href="#rid5">5</a>]. Two controlled trials comparing nasogastric with nasojejunal feedings found no significant differences in APACHE II scores, CRP levels, pain, or analgesic requirements [<a href="#rid41">41-43</a>]. However, another small study comparing nasogastric feeding with TPN noted increased pulmonary and total complications in the nasogastric group [<a href="#rid44">44</a>]. </p><p>We use high protein, low fat, semi-elemental feeding formulas (eg, Peptamen AF) because of a reduction in pancreatic digestive enzymes. We start at 25 cc per hour and advance as tolerated to at least 30 percent of the calculated daily requirement (25 kcal/kg ideal body weight), even in the presence of ileus. Signs that the formula is not tolerated include increased abdominal pain, vomiting (with nasogastric feeding), bloating, or diarrhea (&gt;5 watery stools or &gt;500 mL per 24 hours with exclusion of <em>Clostridioides </em>[formerly <em>Clostridium</em>] <em>difficile</em> toxin and medication-induced diarrhea) that resolves if the feeding is held.</p><p>Enteral nutrition helps maintain the intestinal barrier and prevents bacterial translocation from the gut. Another advantage of enteral nutrition is the avoidance of the complications associated with <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a> including those secondary to venous access and blood stream infections. Consistent with prior meta-analyses, a 2010 meta-analysis of eight trials demonstrated that enteral nutrition significantly reduced mortality, multiple organ failure, systemic infections, and the need for surgery as compared with those who received parenteral nutrition [<a href="#rid45">45-48</a>]. </p><p>The presence of fluid collections or elevated pancreatic enzymes is not necessarily a contraindication to enteral feeding. However, in a subgroup of patients there is clear correlation of pain, recurrence of pancreatitis, or worsening of fluid collections with feeding. These patients often have disrupted pancreatic ducts with fluid collections. Drainage of fluid collections may allow resumption of oral intake. The diagnosis and management of pancreatic duct disruptions is discussed in detail, separately. (See  <a class="medical medical_review" href="/d/html/2658.html" rel="external">"Pancreatic stenting at endoscopic retrograde cholangiopancreatography (ERCP): Indications, techniques, and complications", section on 'Pancreatic duct leakage'</a>.)</p><p class="headingAnchor" id="H6"><span class="h3">Parenteral</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">Parenteral nutrition</a> should be initiated only in patients who do not tolerate enteral feeding or if the target rate of enteral feeding is not achieved within 48 to 72 hours, as the use of parenteral nutrition as an adjunct to enteral feeding may be harmful [<a href="#rid49">49,50</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>An observational study that included 2920 mechanically ventilated, critically ill adults compared 60-day mortality in patients who received enteral nutrition alone, enteral nutrition plus early <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a>, and enteral nutrition plus late parenteral nutrition [<a href="#rid50">50</a>]. Enteral nutrition plus either early or late parenteral nutrition was associated with increased mortality as compared with enteral nutrition alone (35 versus 28 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a randomized trial, 4640 critically ill adults receiving enteral nutrition were assigned to supplemental <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a> initiated early (within 48 hours of ICU admission) or late (after the eighth day of ICU admission) [<a href="#rid49">49</a>]. Compared with the early-initiation group, patients in the late-initiation group had lower rates of ICU infections (23 versus 26 percent), and fewer mechanical ventilation and renal replacement therapy days (relative risk reduction 10 percent). (See  <a class="medical medical_review" href="/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription"</a>.) </p><p></p><p class="headingAnchor" id="H28023696"><span class="h2">Antibiotics</span><span class="headingEndMark"> — </span>Up to 20 percent of patients with acute pancreatitis develop an extrapancreatic infection (eg, bloodstream infections, pneumonia, and urinary tract infections) [<a href="#rid51">51</a>]. Extrapancreatic infections are associated with an increase in mortality [<a href="#rid52">52</a>]. When an infection is suspected, antibiotics should be started while the source of the infection is being determined. However, if cultures are negative and no source of infection is identified, antibiotics should be discontinued.</p><p>Prophylactic antibiotics are not recommended in patients with acute pancreatitis, regardless of the type (interstitial or necrotizing) or disease severity (mild, moderately severe, or severe) [<a href="#rid3">3,5</a>]. The use of antibiotics in patients with suspected infected pancreatic necrosis is discussed separately. (See <a class="local">'Classification'</a> above and <a class="local">'Acute necrotic collection and walled-off necrosis'</a> below.)</p><p class="headingAnchor" id="H28023243"><span class="h2">Other therapies with no role</span></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9757" href="/d/drug information/9757.html" rel="external">Pentoxifylline</a> – Studies are needed to determine the role of pentoxifylline, a nonselective phosphodiesterase inhibitor, in the treatment of acute pancreatitis. In a randomized trial, 28 patients with predicted severe acute pancreatitis were assigned to pentoxifylline or placebo within 72 hours of diagnosis for 72 hours thereafter or until discharge [<a href="#rid53">53</a>]. Patients treated with pentoxifylline had fewer ICU admissions and hospital stays longer than four days as compared with placebo (zero versus four and two versus eight, respectively). However, there were no significant differences in the levels of inflammatory markers, including circulating tumor necrosis factor-alpha levels, between the two groups. Of note, 102 of the 132 (77 percent) patients approached to enter the study declined to participate. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antifungals</strong> – Administration of prophylactic antifungal therapy (eg, <a class="drug drug_general" data-topicid="8450" href="/d/drug information/8450.html" rel="external">fluconazole</a>) along with prophylactic or therapeutic antibiotics is not recommended [<a href="#rid3">3</a>]. Fungal infections occur in approximately 9 percent of necrotizing pancreatitis. However, it is not clear if they are associated with higher mortality [<a href="#rid54">54</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Protease inhibitors</strong> – The role of protease inhibitors in the treatment of acute pancreatitis remains unclear as evidence from clinical trials and a meta-analysis demonstrated only marginal reduction in mortality in patients with severe pancreatitis. Intra-arterial administration is another disadvantage [<a href="#rid55">55-59</a>]. We do not recommend them at the current time.</p><p></p><p class="headingAnchor" id="H540132454"><span class="h1">MANAGEMENT OF COMPLICATIONS</span><span class="headingEndMark"> — </span>Patients with moderately severe or severe acute pancreatitis, signs of sepsis, or clinical deterioration 72 hours after initial presentation should undergo a contrast-enhanced computed tomography scan to assess the presence of pancreatic or extrapancreatic necrosis and local complications. Patients with persistent organ failure and extensive local complications should be transferred to centers of expertise [<a href="#rid10">10</a>]. (See <a class="local">'Classification'</a> above.)</p><p class="headingAnchor" id="H547873037"><span class="h2">Local complications</span><span class="headingEndMark"> — </span>Local complications of acute pancreatitis include acute peripancreatic fluid collection, pancreatic pseudocyst, acute necrotic collection, and walled-off necrosis  (<a class="graphic graphic_table graphicRef87683" data-inline-graphics="87683" href="/d/graphic/87683.html" rel="external">table 3</a>) [<a href="#rid7">7</a>]. While acute peripancreatic fluid collections and acute necrotic collections may develop less than four weeks after the onset of pancreatitis, pancreatic pseudocyst and walled-off necrosis usually occur more than four weeks after the onset of acute pancreatitis.</p><p class="headingAnchor" id="H106842159"><span class="h3">Acute peripancreatic fluid collection</span><span class="headingEndMark"> — </span>Fluid collections usually develop in the early phase of pancreatitis. Acute peripancreatic fluid collections (APFC) do not have a well-defined wall, usually remain asymptomatic, and resolve spontaneously without the need for drainage  (<a class="graphic graphic_diagnosticimage graphicRef88431" href="/d/graphic/88431.html" rel="external">image 1</a>). In a longitudinal study of patients with interstitial pancreatitis, most acute fluid collections resolved within 7 to 10 days with only 6.8 percent of APFCs persisting beyond four weeks as pancreatic pseudocysts [<a href="#rid60">60</a>].</p><p class="headingAnchor" id="H106842165"><span class="h3">Pancreatic pseudocyst</span><span class="headingEndMark"> — </span>A pancreatic pseudocyst is an encapsulated collection of fluid with a well-defined inflammatory wall usually outside the pancreas with minimal or no necrosis  (<a class="graphic graphic_diagnosticimage graphicRef80720" href="/d/graphic/80720.html" rel="external">image 2</a>). Pancreatic pseudocysts usually occur more than four weeks after the onset of interstitial edematous pancreatitis. The management of pancreatic pseudocysts is discussed in detail, separately. (See  <a class="medical medical_review" href="/d/html/5651.html" rel="external">"Approach to walled-off pancreatic fluid collections in adults"</a>.)</p><p class="headingAnchor" id="H106842171"><span class="h3">Acute necrotic collection and walled-off necrosis</span><span class="headingEndMark"> — </span>Necrotizing pancreatitis most commonly manifests as necrosis involving both the pancreas and peripancreatic tissues. Necrosis may result in an acute necrotic collection (ANC) that contains a variable amount of fluid and necrosis but lacks a definable wall  (<a class="graphic graphic_diagnosticimage graphicRef88434" href="/d/graphic/88434.html" rel="external">image 3</a>) or walled-off necrosis (WON), which consists of a mature, encapsulated collection of pancreatic and/or peripancreatic necrosis that has developed a well-defined inflammatory wall. Both ANC and WON are initially sterile but may become infected. The management of walled-off pancreatic fluid collections is discussed in detail, separately. (See  <a class="medical medical_review" href="/d/html/5651.html" rel="external">"Approach to walled-off pancreatic fluid collections in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infected necrosis</strong> – The occurrence of pancreatic infection is a leading cause of morbidity and mortality in acute necrotizing pancreatitis  (<a class="graphic graphic_diagnosticimage graphicRef88436" href="/d/graphic/88436.html" rel="external">image 4</a>). Approximately one-third of patients with pancreatic necrosis develop infected necrosis [<a href="#rid40">40</a>]. There is no correlation between the extent of necrosis and the risk of infection. Although infection can occur early in the course of necrotizing pancreatitis, it is more often seen late in the clinical course (after 10 days) [<a href="#rid61">61,62</a>]. The majority of infections (approximately 75 percent) are monomicrobial with gut-derived organisms (eg, <em>Escherichia coli, Pseudomonas, Klebsiella, </em>and<em> Enterococcus)</em>.</p><p></p><p class="bulletIndent1">Infected necrosis  (<a class="graphic graphic_diagnosticimage graphicRef88436" href="/d/graphic/88436.html" rel="external">image 4</a> and <a class="graphic graphic_diagnosticimage graphicRef73456" href="/d/graphic/73456.html" rel="external">image 5</a>) should be suspected in patients with pancreatic or extrapancreatic necrosis who deteriorate (clinical instability or sepsis physiology, increasing white blood cell count, fevers) or fail to improve after 7 to 10 days of hospitalization. Clinical signs of infection and abdominal imaging demonstrating the presence of gas within the necrosis are reasonably suggestive of infection and antibiotic therapy can be initiated without aspiration and culture [<a href="#rid3">3,4</a>]. If empiric antibiotics are initiated, antibiotics known to penetrate pancreatic necrosis (eg, a carbapenem alone; or a quinolone, <a class="drug drug_general" data-topicid="9226" href="/d/drug information/9226.html" rel="external">ceftazidime</a>, or <a class="drug drug_general" data-topicid="9215" href="/d/drug information/9215.html" rel="external">cefepime</a> combined with an anaerobic agent such as <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a>) should be used. </p><p></p><p class="bulletIndent1">In patients who fail to improve, we perform debridement of pancreatic necrosis (necrosectomy) [<a href="#rid57">57,61</a>]. However, in stable patients with infected necrosis, we attempt to delay necrosectomy by continuing antibiotics for at least four weeks. Continued conservative management of necrotic fluid collection allows a minimally invasive debridement to be performed at a later date to clear necrotic debris [<a href="#rid63">63-66</a>]. In addition, some patients with infected necrosis clinically improve to an extent that no intervention is necessary. Interim percutaneous drainage may be needed in patients with infected necrosis who exhibit clinical deterioration or fail to improve, but do not have a walled-off necrotic collection. However, routine immediate drainage once infected necrosis is diagnosed does not improve outcomes. This was demonstrated in a multicenter, randomized trial in which 104 patients were randomly assigned to immediate drainage (55 patients) or postponed drainage (49 patients) when necrotic collections were largely walled-off, but there was either clinical deterioration or lack of improvement [<a href="#rid67">67</a>]. There was no difference in the rate of complications or mortality between the two groups, however, the mean number of interventions (catheter drainage and necrosectomy) was higher in the immediate drainage group as compared with the postponed drainage group (4.4 versus 2.6 mean difference, 1.8; 95% CI 0.6-3.0). Thirty-nine percent of infected necrosis improved just with antibiotics without the need for any other intervention. Necrosectomy should be accomplished initially by a minimally invasive approach (endoscopic or percutaneous radiologic). Surgical necrosectomy should be used if minimally invasive methods are not possible or fail [<a href="#rid4">4,68-70</a>]. The technique, efficacy, and complications associated with percutaneous, endoscopic, and surgical necrosectomy are discussed in detail, separately. (See  <a class="medical medical_review" href="/d/html/5651.html" rel="external">"Approach to walled-off pancreatic fluid collections in adults", section on 'Percutaneous drainage'</a> and  <a class="medical medical_review" href="/d/html/5650.html" rel="external">"Endoscopic interventions for walled-off pancreatic fluid collections"</a> and  <a class="medical medical_review" href="/d/html/15110.html" rel="external">"Pancreatic debridement"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sterile necrosis</strong> – If the aspirated material on CT-guided FNA is sterile, we discontinue antibiotics and continue conservative treatment for four to six weeks. The use of antibiotics in patients with sterile necrosis to prevent the development of infected necrosis is not recommended. Sterile necrosis does not require therapy.</p><p></p><p class="bulletIndent1">Indications for intervention (radiological, endoscopic, or surgical) in a patient with sterile necrosis with no signs of an infection (eg, fever, hypotension, leukocytosis) include [<a href="#rid4">4,39</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ongoing gastric outlet, intestinal, or biliary obstruction due to mass effect four to eight weeks after onset of acute pancreatitis.</p><p class="bulletIndent2"><span class="glyph">•</span>Persistent symptoms (eg, abdominal pain, nausea, vomiting, anorexia or weight loss) &gt;8 weeks after the onset of acute pancreatitis.</p><p class="bulletIndent2"><span class="glyph">•</span>Disconnected duct syndrome (full transection of the pancreatic duct) with persisting symptomatic collections with necrosis (eg, pain, obstruction) &gt;8 weeks after the onset of acute pancreatitis.</p><p></p><p class="bulletIndent1">In patients with sterile necrosis and signs of systemic toxicity (eg, fever, hypotension, leukocytosis), we repeat CT-guided FNA in five to seven days [<a href="#rid58">58</a>].</p><p></p><p class="headingAnchor" id="H28023409"><span class="h2">Peripancreatic vascular complications</span></p><p class="headingAnchor" id="H126065841"><span class="h3">Splanchnic venous thrombosis</span><span class="headingEndMark"> — </span>Splanchnic vein thrombosis (splenic, portal, and/or superior mesenteric veins) is incidentally found on imaging in 1 to 24 percent of patients with acute pancreatitis, depending on the disease severity and the imaging modality [<a href="#rid71">71</a>]. </p><p></p><p>Treatment should focus on the underlying pancreatitis as effective treatment may result in spontaneous resolution of the thrombosis. Despite the theoretical possibility of hemorrhage into pancreatic necrosis or fluid collections, anticoagulation should be initiated if there is extension of the clot into the portal or superior mesenteric vein resulting in hepatic decompensation or compromise of bowel perfusion. In contrast with patients who have splanchnic vein thrombosis due to chronic pancreatitis, complications such as variceal bleeding are rare and therefore prophylactic splenectomy is not recommended [<a href="#rid72">72</a>]. (See  <a class="medical medical_review" href="/d/html/3579.html" rel="external">"Acute portal vein thrombosis in adults: Clinical manifestations, diagnosis, and management", section on 'Management'</a>.)</p><p class="headingAnchor" id="H126065847"><span class="h3">Pseudoaneurysm</span><span class="headingEndMark"> — </span>Pseudoaneurysms are a rare but serious complication of acute pancreatitis that should be suspected when patients with acute pancreatitis have unexplained gastrointestinal bleeding, an unexplained drop in hematocrit, or sudden expansion of a pancreatic fluid collection. The diagnosis and management of pancreatic pseudoaneurysms are discussed separately. </p><p class="headingAnchor" id="H28023415"><span class="h2">Abdominal compartment syndrome</span><span class="headingEndMark"> — </span>Abdominal compartment syndrome is defined as sustained intra-abdominal pressure &gt;20 mmHg with new onset organ failure [<a href="#rid4">4</a>]. Patients with severe pancreatitis are at increased risk for intra-abdominal hypertension and abdominal compartment syndrome due to tissue edema from aggressive fluid resuscitation, peripancreatic inflammation, ascites, and ileus [<a href="#rid73">73</a>]. Patients in the intensive care unit should be monitored for potential abdominal compartment syndrome with serial measures of urinary bladder pressures [<a href="#rid30">30</a>]. The clinical presentation, diagnosis, and management of abdominal compartment syndrome are discussed in detail, separately. (See  <a class="medical medical_review" href="/d/html/2889.html" rel="external">"Abdominal compartment syndrome in adults", section on 'Clinical presentation'</a>.)</p><p class="headingAnchor" id="H547873132"><span class="h2">Systemic complications</span><span class="headingEndMark"> — </span>Patients with acute pancreatitis are at increased risk for exacerbation of underlying comorbidities (eg, coronary artery disease, chronic lung disease). In addition to treating these exacerbations, patients should be treated for other complications including alcohol withdrawal and hyperglycemia.</p><p>Patients with acute pancreatitis are also at an increased risk of developing prediabetes and diabetes after their first episode of acute pancreatitis [<a href="#rid74">74</a>]. In a 2014 meta-analysis of 24 prospective studies that included 1102 patients with a first episode of acute pancreatitis, 15 percent of individuals were diagnosed with new onset of diabetes mellitus within 12 months. The risk of diabetes significantly increased five years after the first episode of acute pancreatitis (RR 2.7, 95% CI 1.9-3.8). (See  <a class="medical medical_review" href="/d/html/323.html" rel="external">"Management of moderate and severe alcohol withdrawal syndromes"</a> and  <a class="medical medical_review" href="/d/html/1600.html" rel="external">"Glycemic control in critically ill adult and pediatric patients", section on 'Our approach'</a>.)</p><p class="headingAnchor" id="H13"><span class="h1">MANAGEMENT OF UNDERLYING PREDISPOSING CONDITIONS</span><span class="headingEndMark"> — </span>In addition to treating pancreatic inflammation and its associated complications in patients with acute pancreatitis, it is important to address the underlying predisposing factors. For example, drugs associated with acute pancreatitis should be discontinued. (See  <a class="medical medical_review" href="/d/html/5640.html" rel="external">"Etiology of acute pancreatitis", section on 'Medications'</a> and  <a class="medical medical_review" href="/d/html/1897.html" rel="external">"Unique aspects of gastrointestinal disease in patients on dialysis", section on 'Acute pancreatitis'</a>.)</p><p class="headingAnchor" id="H14"><span class="h2">Gallstone pancreatitis</span><span class="headingEndMark"> — </span>In patients with gallstone pancreatitis, most stones pass into the duodenum. However, in a small proportion of patients, obstructive stones in the biliary tract or ampulla of Vater can cause persistent biliary and pancreatic duct obstruction leading to acute pancreatitis and cholangitis. (See  <a class="medical medical_review" href="/d/html/5640.html" rel="external">"Etiology of acute pancreatitis"</a> and  <a class="medical medical_review" href="/d/html/5652.html" rel="external">"Clinical manifestations and diagnosis of acute pancreatitis"</a>.)</p><p class="headingAnchor" id="H15"><span class="h3">Endoscopic retrograde cholangiopancreatography</span><span class="headingEndMark"> — </span>Endoscopic retrograde cholangiopancreatography (ERCP) should be performed early in the course (within 24 hours of admission) for patients with gallstone pancreatitis and cholangitis. Other indications for ERCP include patients with common bile duct obstruction (visible stone on imaging), dilated common bile duct, or increasing liver tests without cholangitis. </p><p>In the absence of common bile duct obstruction, ERCP is not indicated for (mild or severe) gallstone pancreatitis without cholangitis. When in doubt about bile duct obstruction in the absence of cholangitis, liver tests can be rechecked in 24 to 48 hours to determine if they improve or a magnetic resonance cholangiopancreatography (MRCP) or endoscopic ultrasound (EUS) could be performed to determine if there are stones in the common bile duct.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications for EUS/MRCP prior to ERCP</strong> – EUS or MRCP should be performed to determine the need for ERCP in the following patients: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Persistent elevation of liver tests and/or dilation of common bile duct without overt cholangitis</p><p class="bulletIndent2"><span class="glyph">•</span>Pregnant patients</p><p class="bulletIndent2"><span class="glyph">•</span>Altered anatomy that would make an ERCP technically challenging </p><p></p><p class="bulletIndent1">In patients who are found to have stones on EUS or MRCP, ERCP with sphincterotomy and stone extraction is necessary and will prevent future attacks of biliary pancreatitis. However, in the absence of a cholecystectomy, these patients remain at risk for acute cholecystitis, biliary colic, and gallbladder complications of cholelithiasis. </p><p></p><p>In patients with acute cholangitis and persistent obstruction, urgent (&lt;24 hours) ERCP with papillotomy or surgical intervention to remove bile duct stones may lessen the severity of gallstone pancreatitis [<a href="#rid4">4,75-78</a>].</p><p>In patients with gallstone pancreatitis and persistent obstruction <strong>without</strong> cholangitis, urgent ERCP (within 24 hours) is not indicated [<a href="#rid5">5,6,79,80</a>]. In such patients, therapeutic ERCP can be performed either before the cholecystectomy, if there is a strong suspicion of stone in the bile duct, or postoperatively, if intra-operative cholangiogram demonstrates a stone [<a href="#rid4">4,5</a>]. In a systematic review of eight randomized trials, early ERCP in patients without cholangitis did not lead to a significant reduction in the risk of overall pancreatic complications, single organ failure or mortality [<a href="#rid6">6</a>]. However, one trial demonstrated a reduction in the length of hospital stay with urgent ERCP.</p><p class="headingAnchor" id="H16"><span class="h3">Cholecystectomy</span><span class="headingEndMark"> — </span>Cholecystectomy should be performed after recovery in all patients with gallstone pancreatitis including those who have undergone an endoscopic sphincterotomy [<a href="#rid81">81</a>]. In patients who have had mild pancreatitis, cholecystectomy can usually be performed safely within seven days after recovery and in the same index hospitalization [<a href="#rid82">82,83</a>]. A randomized controlled trial demonstrated a reduction in composite outcome of mortality and biliary complications and readmissions due to attacks of acute pancreatitis [<a href="#rid84">84</a>]. </p><p></p><p>In those patients initially diagnosed as interstitial acute biliary pancreatitis and undergoing same admission cholecystectomy, a high white count or presence of SIRS indicates evolving necrotizing pancreatitis and cholecystectomy in those patients resulted in higher incidence of organ failure and infected necrosis [<a href="#rid85">85</a>]. A repeat CT scan before cholecystectomy is advised. In patients who have had severe necrotizing pancreatitis, cholecystectomy should be delayed until active inflammation subsides and fluid collections resolve or stabilize [<a href="#rid82">82</a>]. </p><p>Failure to perform a cholecystectomy is associated with a 25 to 30 percent risk of recurrent acute pancreatitis, cholecystitis, or cholangitis within 6 to 18 weeks [<a href="#rid86">86</a>]. The risk of recurrent pancreatitis is highest in patients who have not undergone a sphincterotomy. (See  <a class="medical medical_review" href="/d/html/674.html" rel="external">"Endoscopic management of bile duct stones", section on 'ERCP-guided stone removal'</a>.)</p><p>If the clinical suspicion of common bile duct stones is high (eg, in those with persistent or worsening liver test abnormalities or cholangitis), a preoperative ERCP is the best test as there is a high likelihood that therapeutic intervention (sphincterotomy, stone extraction) will be required. If the suspicion of persistent common bile duct stones is low (eg, if liver tests normalize), an intraoperative cholangiogram during cholecystectomy is preferable to avoid the morbidity associated with ERCP. In patients with low to moderate likelihood, MRCP or EUS should be performed preoperatively to exclude common bile duct stones [<a href="#rid87">87</a>]. A preoperative ERCP can then be performed in those with stones or sludge in the common bile duct. </p><p class="headingAnchor" id="H266287453"><span class="h2">Biliary sludge</span><span class="headingEndMark"> — </span>Most patients with biliary sludge are asymptomatic. However, biliary sludge is commonly found in 20 to 40 percent of patients with acute pancreatitis with no other obvious cause. On ultrasound, sludge appears as a mobile, low-amplitude echo that layers in the most dependent part of the gallbladder and is not associated with shadowing. However, ultrasound has a low sensitivity for biliary sludge. If the cause is not clear, we perform EUS, even after one attack, to look for microlithiasis in the gallbladder or bile duct. Cholecystectomy should be performed in patients who have had an episode of pancreatitis and have biliary sludge [<a href="#rid31">31,35</a>]. Studies suggest that biliary sludge can lead to pancreatitis and that these patients may benefit from intervention [<a href="#rid88">88,89</a>]. In a randomized trial, 85 patients, after their first attack of idiopathic acute pancreatitis, were assigned to laparoscopic cholecystectomy or conservative watchful waiting [<a href="#rid90">90</a>]. During a median follow-up of 36 months, significantly fewer patients who had undergone laparoscopic cholecystectomy had recurrent idiopathic acute pancreatitis as compared with controls (10 versus 30 percent). A total of five patients needed to be treated to prevent one episode of what was thought to be idiopathic acute pancreatitis. However, EUS was not performed to detect small gallstones or biliary sludge. Biliary stones or sludge were detected during surgery in 23 of 39 patients (59 percent) who underwent cholecystectomy. (See  <a class="medical medical_review" href="/d/html/5640.html" rel="external">"Etiology of acute pancreatitis", section on 'Approach to establishing the underlying etiology'</a> and  <a class="medical medical_review" href="/d/html/5640.html" rel="external">"Etiology of acute pancreatitis", section on 'Biliary sludge and microlithiasis'</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">Hypertriglyceridemia</span><span class="headingEndMark"> — </span>The treatment of hypertriglyceridemic pancreatitis is discussed separately. (See  <a class="medical medical_review" href="/d/html/5655.html" rel="external">"Hypertriglyceridemia-induced acute pancreatitis"</a>.)</p><p class="headingAnchor" id="H1417528"><span class="h2">Hypercalcemia</span><span class="headingEndMark"> — </span>Hypercalcemia is a rare cause of acute pancreatitis. If present, treatment should be directed at normalizing serum calcium levels and determining the underlying etiology. (See  <a class="medical medical_review" href="/d/html/839.html" rel="external">"Etiology of hypercalcemia"</a> and  <a class="medical medical_review" href="/d/html/836.html" rel="external">"Diagnostic approach to hypercalcemia"</a> and  <a class="medical medical_review" href="/d/html/850.html" rel="external">"Treatment of hypercalcemia"</a> and  <a class="medical medical_review" href="/d/html/5640.html" rel="external">"Etiology of acute pancreatitis", section on 'Hypercalcemia'</a>.)</p><p class="headingAnchor" id="H1488361912"><span class="h2">Alcoholic pancreatitis</span><span class="headingEndMark"> — </span>Patients with alcoholic pancreatitis should receive brief alcohol intervention as inpatients for unhealthy alcohol use [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/d/html/115659.html" rel="external">"Brief intervention for unhealthy alcohol and other drug use: Goals and components"</a> and  <a class="medical medical_review" href="/d/html/14832.html" rel="external">"Brief intervention for unhealthy alcohol and other drug use: Efficacy, adverse effects, and administration"</a>.)</p><p class="headingAnchor" id="H643084063"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/111701.html" rel="external">"Society guideline links: Acute pancreatitis"</a>.)</p><p class="headingAnchor" id="H2257185932"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/15433.html" rel="external">"Patient education: Acute pancreatitis (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/1997.html" rel="external">"Patient education: Acute pancreatitis (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H20"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Classification of acute pancreatitis</strong> – Acute pancreatitis is an acute inflammatory process of the pancreas. Acute pancreatitis can be divided into two broad categories: edematous, interstitial acute pancreatitis and necrotizing acute pancreatitis. Mild acute pancreatitis is characterized by the absence of organ failure and local or systemic complications. Moderately severe acute pancreatitis is characterized by no organ failure or transient organ failure (&lt;48 hours) and/or local complications. Severe acute pancreatitis is characterized by persistent organ failure (&gt;48 hours) that may involve one or multiple organs. (See <a class="local">'Classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial evaluation</strong> – At initial evaluation, the severity of acute pancreatitis should be assessed by clinical examination to assess for early fluid losses, organ failure  (<a class="graphic graphic_table graphicRef87718" href="/d/graphic/87718.html" rel="external">table 1</a>), and systemic inflammatory response syndrome (SIRS) score. Routine abdominal computed tomography (CT) scan is not recommended at initial presentation in patients with acute pancreatitis unless there is uncertainty about the diagnosis. (See <a class="local">'Assessment of disease severity'</a> above and  <a class="medical medical_review" href="/d/html/5639.html" rel="external">"Predicting the severity of acute pancreatitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indication for monitored or intensive care unit</strong> – Admission to a monitored or intensive care unit is indicated in patients with severe acute pancreatitis and in patients with acute pancreatitis who meet one or more of the following parameters (see <a class="local">'Indications for monitored or intensive care'</a> above): </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pulse &lt;40 or &gt;150 beats/minute</p><p class="bulletIndent2"><span class="glyph">•</span>Systolic arterial pressure &lt;80 mmHg or mean arterial pressure &lt;60 mmHg or diastolic arterial pressure &gt;120 mmHg</p><p class="bulletIndent2"><span class="glyph">•</span>Respiratory rate &gt;35 breaths/minute</p><p class="bulletIndent2"><span class="glyph">•</span>Serum sodium &lt;110 mmol/L or &gt;170 mmol/L, serum potassium &lt;2.0 mmol/L or &gt;7.0 mmol/L, serum glucose &gt;800 mg/dL, serum calcium &gt;15 mg/dL</p><p class="bulletIndent2"><span class="glyph">•</span>PaO<sub>2</sub> &lt;50 mmHg</p><p class="bulletIndent2"><span class="glyph">•</span>pH &lt;7.1 or &gt;7.7</p><p class="bulletIndent2"><span class="glyph">•</span>Anuria</p><p class="bulletIndent2"><span class="glyph">•</span>Coma</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fluid replacement</strong> – Acute pancreatitis is treated with supportive care including pain control, goal-directed intravenous fluids especially during the first 24 hours, and correction of electrolyte and metabolic abnormalities. The majority of patients with mild pancreatitis require no further therapy, and recover within three to seven days. Patients with moderately severe and severe pancreatitis require more intensive monitoring as they have transient (&lt;48 hours) or persistent (&gt;48 hours) organ failure and local or systemic complications.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pain control</strong> – Abdominal pain is often the predominant symptom in patients with acute pancreatitis. Adequate pain control requires the use of intravenous opiates, such as <a class="drug drug_general" data-topicid="9788" href="/d/drug information/9788.html" rel="external">morphine</a> and <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a>, usually in the form of a patient-controlled analgesia pump. (See <a class="local">'Pain control'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nutrition</strong> – In patients with mild pancreatitis, recovery generally occurs quickly, making it unnecessary to initiate supplemental nutrition. A soft diet can be started early (within 24 hours) as tolerated if the pain is decreasing and inflammatory markers are improving. We usually start with a low-residue, low-fat, and soft diet, provided there is no evidence of ileus or significant nausea and/or vomiting. </p><p></p><p class="bulletIndent1">In patients with severe pancreatitis, we recommend enteral nutrition through a nasojejunal tube placed endoscopically or radiologically rather than initiating <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a> (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). If the target rate is not achieved within 48 to 72 hours and if severe acute pancreatitis is not resolved, supplemental parenteral nutrition should be provided. (See <a class="local">'Oral'</a> above and <a class="local">'Enteral'</a> above and <a class="local">'Parenteral'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications for follow-up imaging</strong> – Patients with moderately severe or severe acute pancreatitis, signs of sepsis, or clinical deterioration 72 hours after initial presentation, should undergo a contrast-enhanced CT scan to assess the presence of pancreatic or extrapancreatic necrosis and local complications. Patients with persistent organ failure and extensive local complications should be transferred to centers of expertise. (See <a class="local">'Management of complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications of acute pancreatitis</strong> – Patients with pancreatitis may develop local or systemic complications. Local complications of acute pancreatitis include acute peripancreatic fluid collection, pancreatic pseudocyst, acute necrotic collection (ANC), and walled-off necrosis (WON)  (<a class="graphic graphic_table graphicRef87683" href="/d/graphic/87683.html" rel="external">table 3</a>). While acute peripancreatic fluid collections and acute necrotic collections may develop less than four weeks after the onset of pancreatitis, pancreatic pseudocyst and walled-off necrosis usually occur more than four weeks after the onset of acute pancreatitis. (See <a class="local">'Local complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with infected necrosis </strong>– Both acute necrotic collection and WON are initially sterile but may become infected. The occurrence of pancreatic infection is a leading cause of morbidity and mortality in acute necrotizing pancreatitis. Infected necrosis  (<a class="graphic graphic_diagnosticimage graphicRef88436" href="/d/graphic/88436.html" rel="external">image 4</a>) should be suspected in patients with pancreatic or extrapancreatic necrosis who deteriorate (clinical instability or sepsis physiology, increasing white blood cell count, fevers) or fail to improve after 7 to 10 days of hospitalization. In patients with suspected infected necrosis, we suggest empiric antibiotics rather than CT-guided fine needle aspiration (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Acute necrotic collection and walled-off necrosis'</a> above.)</p><p></p><p class="bulletIndent1">Patients with infected necrosis who fail to respond to antibiotics or who are clinically unstable, may require pancreatic debridement. Where possible, we attempt to delay intervention until four weeks after initial presentation to allow the infected necrosis to become walled off. We perform necrosectomy with minimally invasive methods and reserve open surgical debridement for patients who are clinically unstable or if minimally invasive debridement is not possible or fails. (See <a class="local">'Acute necrotic collection and walled-off necrosis'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with gallstone pancreatitis</strong> – In patients with gallstone pancreatitis, we recommend urgent (&lt;24 hours) endoscopic retrograde cholangiopancreatography and sphincterotomy for patients with cholangitis (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). Cholecystectomy should be performed after recovery from acute pancreatitis in all operable patients with gallstone pancreatitis or biliary sludge. (See <a class="local">'Gallstone pancreatitis'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Singh VK, Bollen TL, Wu BU, et al. An assessment of the severity of interstitial pancreatitis. Clin Gastroenterol Hepatol 2011; 9:1098.</a></li><li><a class="nounderline abstract_t">van Santvoort HC, Bakker OJ, Bollen TL, et al. A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology 2011; 141:1254.</a></li><li><a class="nounderline abstract_t">Tenner S, Baillie J, DeWitt J, et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol 2013; 108:1400.</a></li><li><a class="nounderline abstract_t">Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 2013; 13:e1.</a></li><li><a class="nounderline abstract_t">Crockett SD, Wani S, Gardner TB, et al. American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis. Gastroenterology 2018; 154:1096.</a></li><li><a class="nounderline abstract_t">Vege SS, DiMagno MJ, Forsmark CE, et al. Initial Medical Treatment of Acute Pancreatitis: American Gastroenterological Association Institute Technical Review. Gastroenterology 2018; 154:1103.</a></li><li><a class="nounderline abstract_t">Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62:102.</a></li><li><a class="nounderline abstract_t">Johnson C, Charnley R, Rowlands B, et al. UK guidelines for the management of acute pancreatitis. Gut 2005; 54 Suppl 3:1.</a></li><li><a class="nounderline abstract_t">Guidelines for intensive care unit admission, discharge, and triage. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med 1999; 27:633.</a></li><li><a class="nounderline abstract_t">Wu BU, Banks PA. Clinical management of patients with acute pancreatitis. Gastroenterology 2013; 144:1272.</a></li><li><a class="nounderline abstract_t">Talukdar R, Swaroop Vege S. Early management of severe acute pancreatitis. Curr Gastroenterol Rep 2011; 13:123.</a></li><li><a class="nounderline abstract_t">Trikudanathan G, Navaneethan U, Vege SS. Current controversies in fluid resuscitation in acute pancreatitis: a systematic review. Pancreas 2012; 41:827.</a></li><li><a class="nounderline abstract_t">Gardner TB, Vege SS, Chari ST, et al. Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes in-hospital mortality. Pancreatology 2009; 9:770.</a></li><li><a class="nounderline abstract_t">Brown A, Baillargeon JD, Hughes MD, Banks PA. Can fluid resuscitation prevent pancreatic necrosis in severe acute pancreatitis? Pancreatology 2002; 2:104.</a></li><li><a class="nounderline abstract_t">Whitcomb DC, Muddana V, Langmead CJ, et al. Angiopoietin-2, a regulator of vascular permeability in inflammation, is associated with persistent organ failure in patients with acute pancreatitis from the United States and Germany. Am J Gastroenterol 2010; 105:2287.</a></li><li><a class="nounderline abstract_t">Wilms H, Mittal A, Haydock MD, et al. A systematic review of goal directed fluid therapy: rating of evidence for goals and monitoring methods. J Crit Care 2014; 29:204.</a></li><li><a class="nounderline abstract_t">de-Madaria E, Buxbaum JL, Maisonneuve P, et al. Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis. N Engl J Med 2022; 387:989.</a></li><li><a class="nounderline abstract_t">Forsmark CE, Vege SS, Wilcox CM. Acute Pancreatitis. N Engl J Med 2016; 375:1972.</a></li><li><a class="nounderline abstract_t">Wu BU, Hwang JQ, Gardner TH, et al. Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol 2011; 9:710.</a></li><li><a class="nounderline abstract_t">Wu BU, Conwell DL. Acute pancreatitis part I: approach to early management. Clin Gastroenterol Hepatol 2010; 8:410.</a></li><li><a class="nounderline abstract_t">Wu BU, Johannes RS, Sun X, et al. Early changes in blood urea nitrogen predict mortality in acute pancreatitis. Gastroenterology 2009; 137:129.</a></li><li><a class="nounderline abstract_t">de-Madaria E, Herrera-Marante I, González-Camacho V, et al. Fluid resuscitation with lactated Ringer's solution vs normal saline in acute pancreatitis: A triple-blind, randomized, controlled trial. United European Gastroenterol J 2018; 6:63.</a></li><li><a class="nounderline abstract_t">Choosakul S, Harinwan K, Chirapongsathorn S, et al. Comparison of normal saline versus Lactated Ringer's solution for fluid resuscitation in patients with mild acute pancreatitis, A randomized controlled trial. Pancreatology 2018; 18:507.</a></li><li><a class="nounderline abstract_t">Lee A, Ko C, Buitrago C, et al. Lactated Ringers vs Normal Saline Resuscitation for Mild Acute Pancreatitis: A Randomized Trial. Gastroenterology 2021; 160:955.</a></li><li><a class="nounderline abstract_t">Gardner TB, Vege SS, Pearson RK, Chari ST. Fluid resuscitation in acute pancreatitis. Clin Gastroenterol Hepatol 2008; 6:1070.</a></li><li><a class="nounderline abstract_t">Haydock MD, Mittal A, Wilms HR, et al. Fluid therapy in acute pancreatitis: anybody's guess. Ann Surg 2013; 257:182.</a></li><li><a class="nounderline abstract_t">Zhao G, Zhang JG, Wu HS, et al. Effects of different resuscitation fluid on severe acute pancreatitis. World J Gastroenterol 2013; 19:2044.</a></li><li><a class="nounderline abstract_t">Basurto Ona X, Rigau Comas D, Urrútia G. Opioids for acute pancreatitis pain. Cochrane Database Syst Rev 2013; :CD009179.</a></li><li><a class="nounderline abstract_t">Helm JF, Venu RP, Geenen JE, et al. Effects of morphine on the human sphincter of Oddi. Gut 1988; 29:1402.</a></li><li><a class="nounderline abstract_t">De Waele JJ, De Laet I, Kirkpatrick AW, Hoste E. Intra-abdominal Hypertension and Abdominal Compartment Syndrome. Am J Kidney Dis 2011; 57:159.</a></li><li><a class="nounderline abstract_t">Eckerwall GE, Tingstedt BB, Bergenzaun PE, Andersson RG. Immediate oral feeding in patients with mild acute pancreatitis is safe and may accelerate recovery--a randomized clinical study. Clin Nutr 2007; 26:758.</a></li><li><a class="nounderline abstract_t">Li J, Xue GJ, Liu YL, et al. Early oral refeeding wisdom in patients with mild acute pancreatitis. Pancreas 2013; 42:88.</a></li><li><a class="nounderline abstract_t">Sathiaraj E, Murthy S, Mansard MJ, et al. Clinical trial: oral feeding with a soft diet compared with clear liquid diet as initial meal in mild acute pancreatitis. Aliment Pharmacol Ther 2008; 28:777.</a></li><li><a class="nounderline abstract_t">Jacobson BC, Vander Vliet MB, Hughes MD, et al. A prospective, randomized trial of clear liquids versus low-fat solid diet as the initial meal in mild acute pancreatitis. Clin Gastroenterol Hepatol 2007; 5:946.</a></li><li><a class="nounderline abstract_t">Moraes JM, Felga GE, Chebli LA, et al. A full solid diet as the initial meal in mild acute pancreatitis is safe and result in a shorter length of hospitalization: results from a prospective, randomized, controlled, double-blind clinical trial. J Clin Gastroenterol 2010; 44:517.</a></li><li><a class="nounderline abstract_t">Vaughn VM, Shuster D, Rogers MAM, et al. Early Versus Delayed Feeding in Patients With Acute Pancreatitis: A Systematic Review. Ann Intern Med 2017; 166:883.</a></li><li><a class="nounderline abstract_t">Roberts KM, Conwell D. Acute Pancreatitis: How Soon Should We Feed Patients? Ann Intern Med 2017; 166:903.</a></li><li><a class="nounderline abstract_t">Bakker OJ, van Brunschot S, van Santvoort HC, et al. Early versus on-demand nasoenteric tube feeding in acute pancreatitis. N Engl J Med 2014; 371:1983.</a></li><li><a class="nounderline abstract_t">Forsmark CE, Baillie J, AGA Institute Clinical Practice and Economics Committee, AGA Institute Governing Board. AGA Institute technical review on acute pancreatitis. Gastroenterology 2007; 132:2022.</a></li><li><a class="nounderline abstract_t">Banks PA, Freeman ML, Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006; 101:2379.</a></li><li><a class="nounderline abstract_t">Eatock FC, Chong P, Menezes N, et al. A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol 2005; 100:432.</a></li><li><a class="nounderline abstract_t">Singh N, Sharma B, Sharma M, et al. Evaluation of early enteral feeding through nasogastric and nasojejunal tube in severe acute pancreatitis: a noninferiority randomized controlled trial. Pancreas 2012; 41:153.</a></li><li><a class="nounderline abstract_t">Kumar A, Singh N, Prakash S, et al. Early enteral nutrition in severe acute pancreatitis: a prospective randomized controlled trial comparing nasojejunal and nasogastric routes. J Clin Gastroenterol 2006; 40:431.</a></li><li><a class="nounderline abstract_t">Eckerwall GE, Axelsson JB, Andersson RG. Early nasogastric feeding in predicted severe acute pancreatitis: A clinical, randomized study. Ann Surg 2006; 244:959.</a></li><li><a class="nounderline abstract_t">McClave SA, Chang WK, Dhaliwal R, Heyland DK. Nutrition support in acute pancreatitis: a systematic review of the literature. JPEN J Parenter Enteral Nutr 2006; 30:143.</a></li><li><a class="nounderline abstract_t">Petrov MS, Pylypchuk RD, Emelyanov NV. Systematic review: nutritional support in acute pancreatitis. Aliment Pharmacol Ther 2008; 28:704.</a></li><li><a class="nounderline abstract_t">Al-Omran M, Albalawi ZH, Tashkandi MF, Al-Ansary LA. Enteral versus parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev 2010; :CD002837.</a></li><li><a class="nounderline abstract_t">Marik PE, Zaloga GP. Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. BMJ 2004; 328:1407.</a></li><li><a class="nounderline abstract_t">Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011; 365:506.</a></li><li><a class="nounderline abstract_t">Kutsogiannis J, Alberda C, Gramlich L, et al. Early use of supplemental parenteral nutrition in critically ill patients: results of an international multicenter observational study. Crit Care Med 2011; 39:2691.</a></li><li><a class="nounderline abstract_t">Besselink MG, van Santvoort HC, Boermeester MA, et al. Timing and impact of infections in acute pancreatitis. Br J Surg 2009; 96:267.</a></li><li><a class="nounderline abstract_t">Wu BU, Johannes RS, Kurtz S, Banks PA. The impact of hospital-acquired infection on outcome in acute pancreatitis. Gastroenterology 2008; 135:816.</a></li><li><a class="nounderline abstract_t">Vege SS, Atwal T, Bi Y, et al. Pentoxifylline Treatment in Severe Acute Pancreatitis: A Pilot, Double-Blind, Placebo-Controlled, Randomized Trial. Gastroenterology 2015; 149:318.</a></li><li><a class="nounderline abstract_t">Trikudanathan G, Navaneethan U, Vege SS. Intra-abdominal fungal infections complicating acute pancreatitis: a review. Am J Gastroenterol 2011; 106:1188.</a></li><li><a class="nounderline abstract_t">Takeda K, Matsuno S, Sunamura M, Kakugawa Y. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis. Am J Surg 1996; 171:394.</a></li><li><a class="nounderline abstract_t">Imaizumi H, Kida M, Nishimaki H, et al. Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit. Pancreas 2004; 28:369.</a></li><li><a class="nounderline abstract_t">Yasuda T, Ueda T, Takeyama Y, et al. Treatment strategy against infection: clinical outcome of continuous regional arterial infusion, enteral nutrition, and surgery in severe acute pancreatitis. J Gastroenterol 2007; 42:681.</a></li><li><a class="nounderline abstract_t">Morimoto A, Imamura T, Ishii R, et al. Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic. Cancer 2008; 113:1362.</a></li><li><a class="nounderline abstract_t">Seta T, Noguchi Y, Shimada T, et al. Treatment of acute pancreatitis with protease inhibitors: a meta-analysis. Eur J Gastroenterol Hepatol 2004; 16:1287.</a></li><li><a class="nounderline abstract_t">Lenhart DK, Balthazar EJ. MDCT of acute mild (nonnecrotizing) pancreatitis: abdominal complications and fate of fluid collections. AJR Am J Roentgenol 2008; 190:643.</a></li><li><a class="nounderline abstract_t">Beger HG, Bittner R, Block S, Büchler M. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 1986; 91:433.</a></li><li><a class="nounderline abstract_t">Bradley EL 3rd, Allen K. A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis. Am J Surg 1991; 161:19.</a></li><li><a class="nounderline abstract_t">Baron TH, Morgan DE. Endoscopic transgastric irrigation tube placement via PEG for debridement of organized pancreatic necrosis. Gastrointest Endosc 1999; 50:574.</a></li><li><a class="nounderline abstract_t">Clancy TE, Ashley SW. Current management of necrotizing pancreatitis. Adv Surg 2002; 36:103.</a></li><li><a class="nounderline abstract_t">Jacobson BC, Baron TH, Adler DG, et al. ASGE guideline: The role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas. Gastrointest Endosc 2005; 61:363.</a></li><li><a class="nounderline abstract_t">Seewald S, Groth S, Omar S, et al. Aggressive endoscopic therapy for pancreatic necrosis and pancreatic abscess: a new safe and effective treatment algorithm (videos). Gastrointest Endosc 2005; 62:92.</a></li><li><a class="nounderline abstract_t">Boxhoorn L, van Dijk SM, van Grinsven J, et al. Immediate versus Postponed Intervention for Infected Necrotizing Pancreatitis. N Engl J Med 2021; 385:1372.</a></li><li><a class="nounderline abstract_t">Freeman ML, Werner J, van Santvoort HC, et al. Interventions for necrotizing pancreatitis: summary of a multidisciplinary consensus conference. Pancreas 2012; 41:1176.</a></li><li><a class="nounderline abstract_t">van Santvoort HC, Besselink MG, Bakker OJ, et al. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med 2010; 362:1491.</a></li><li><a class="nounderline abstract_t">van Brunschot S, van Grinsven J, van Santvoort HC, et al. Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial. Lancet 2018; 391:51.</a></li><li><a class="nounderline abstract_t">Nadkarni NA, Khanna S, Vege SS. Splanchnic venous thrombosis and pancreatitis. Pancreas 2013; 42:924.</a></li><li><a class="nounderline abstract_t">Heider TR, Azeem S, Galanko JA, Behrns KE. The natural history of pancreatitis-induced splenic vein thrombosis. Ann Surg 2004; 239:876.</a></li><li><a class="nounderline abstract_t">Radenkovic DV, Bajec D, Ivancevic N, et al. Decompressive laparotomy with temporary abdominal closure versus percutaneous puncture with placement of abdominal catheter in patients with abdominal compartment syndrome during acute pancreatitis: background and design of multicenter, randomised, controlled study. BMC Surg 2010; 10:22.</a></li><li><a class="nounderline abstract_t">Das S, Singh PP, Phillips A, et al. Newly diagnosed diabetes mellitus after acute pancreatitis: A systematic review and meta-analysis. Gut 2014; 63.</a></li><li><a class="nounderline abstract_t">Rünzi M, Saluja A, Lerch MM, et al. Early ductal decompression prevents the progression of biliary pancreatitis: an experimental study in the opossum. Gastroenterology 1993; 105:157.</a></li><li><a class="nounderline abstract_t">Fan ST, Lai EC, Mok FP, et al. Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med 1993; 328:228.</a></li><li><a class="nounderline abstract_t">van Santvoort HC, Besselink MG, de Vries AC, et al. Early endoscopic retrograde cholangiopancreatography in predicted severe acute biliary pancreatitis: a prospective multicenter study. Ann Surg 2009; 250:68.</a></li><li><a class="nounderline abstract_t">Petrov MS, van Santvoort HC, Besselink MG, et al. Early endoscopic retrograde cholangiopancreatography versus conservative management in acute biliary pancreatitis without cholangitis: a meta-analysis of randomized trials. Ann Surg 2008; 247:250.</a></li><li><a class="nounderline abstract_t">Schepers NJ, Hallensleben NDL, Besselink MG, et al. Urgent endoscopic retrograde cholangiopancreatography with sphincterotomy versus conservative treatment in predicted severe acute gallstone pancreatitis (APEC): a multicentre randomised controlled trial. Lancet 2020; 396:167.</a></li><li><a class="nounderline abstract_t">Tse F, Yuan Y. Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative management strategy in acute gallstone pancreatitis. Cochrane Database Syst Rev 2012; :CD009779.</a></li><li><a class="nounderline abstract_t">Laws HL, Kent RB 3rd. Acute pancreatitis: management of complicating infection. Am Surg 2000; 66:145.</a></li><li><a class="nounderline abstract_t">Uhl W, Müller CA, Krähenbühl L, et al. Acute gallstone pancreatitis: timing of laparoscopic cholecystectomy in mild and severe disease. Surg Endosc 1999; 13:1070.</a></li><li><a class="nounderline abstract_t">Aboulian A, Chan T, Yaghoubian A, et al. Early cholecystectomy safely decreases hospital stay in patients with mild gallstone pancreatitis: a randomized prospective study. Ann Surg 2010; 251:615.</a></li><li><a class="nounderline abstract_t">da Costa DW, Bouwense SA, Schepers NJ, et al. Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial. Lancet 2015; 386:1261.</a></li><li><a class="nounderline abstract_t">Kwong WT, Vege SS. Unrecognized necrosis at same admission cholecystectomy for pancreatitis increases organ failure and infected necrosis. Pancreatology 2017; 17:41.</a></li><li><a class="nounderline abstract_t">Hernandez V, Pascual I, Almela P, et al. Recurrence of acute gallstone pancreatitis and relationship with cholecystectomy or endoscopic sphincterotomy. Am J Gastroenterol 2004; 99:2417.</a></li><li><a class="nounderline abstract_t">Calvo MM, Bujanda L, Calderón A, et al. Role of magnetic resonance cholangiopancreatography in patients with suspected choledocholithiasis. Mayo Clin Proc 2002; 77:422.</a></li><li><a class="nounderline abstract_t">Ros E, Navarro S, Bru C, et al. Occult microlithiasis in 'idiopathic' acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. Gastroenterology 1991; 101:1701.</a></li><li><a class="nounderline abstract_t">Lee SP, Nicholls JF, Park HZ. Biliary sludge as a cause of acute pancreatitis. N Engl J Med 1992; 326:589.</a></li><li><a class="nounderline abstract_t">Räty S, Pulkkinen J, Nordback I, et al. Can Laparoscopic Cholecystectomy Prevent Recurrent Idiopathic Acute Pancreatitis?: A Prospective Randomized Multicenter Trial. Ann Surg 2015; 262:736.</a></li></ol></div><div id="topicVersionRevision">Topic 5633 Version 63.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21893128" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : An assessment of the severity of interstitial pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21741922" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23896955" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : American College of Gastroenterology guideline: management of acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24054878" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : IAP/APA evidence-based guidelines for the management of acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29409760" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29421596" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Initial Medical Treatment of Acute Pancreatitis: American Gastroenterological Association Institute Technical Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23100216" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : UK guidelines for the management of acute pancreatitis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10199547" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Guidelines for intensive care unit admission, discharge, and triage. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23622137" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Clinical management of patients with acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21243452" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Early management of severe acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22781906" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Current controversies in fluid resuscitation in acute pancreatitis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20110744" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes in-hospital mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12123089" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Can fluid resuscitation prevent pancreatic necrosis in severe acute pancreatitis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20461065" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Angiopoietin-2, a regulator of vascular permeability in inflammation, is associated with persistent organ failure in patients with acute pancreatitis from the United States and Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24360819" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A systematic review of goal directed fluid therapy: rating of evidence for goals and monitoring methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36103415" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27959604" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Acute Pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21645639" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19896558" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Acute pancreatitis part I: approach to early management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19344722" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Early changes in blood urea nitrogen predict mortality in acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29435315" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Fluid resuscitation with lactated Ringer's solution vs normal saline in acute pancreatitis: A triple-blind, randomized, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29754857" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Comparison of normal saline versus Lactated Ringer's solution for fluid resuscitation in patients with mild acute pancreatitis, A randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33159924" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Lactated Ringers vs Normal Saline Resuscitation for Mild Acute Pancreatitis: A Randomized Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18619920" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Fluid resuscitation in acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23207241" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Fluid therapy in acute pancreatitis: anybody's guess.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23599623" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Effects of different resuscitation fluid on severe acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23888429" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Opioids for acute pancreatitis pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3197985" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Effects of morphine on the human sphincter of Oddi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21184922" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Intra-abdominal Hypertension and Abdominal Compartment Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17719703" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Immediate oral feeding in patients with mild acute pancreatitis is safe and may accelerate recovery--a randomized clinical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22836861" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Early oral refeeding wisdom in patients with mild acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19145732" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Clinical trial: oral feeding with a soft diet compared with clear liquid diet as initial meal in mild acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17613280" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A prospective, randomized trial of clear liquids versus low-fat solid diet as the initial meal in mild acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20054282" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : A full solid diet as the initial meal in mild acute pancreatitis is safe and result in a shorter length of hospitalization: results from a prospective, randomized, controlled, double-blind clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28505667" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Early Versus Delayed Feeding in Patients With Acute Pancreatitis: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28505666" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Acute Pancreatitis: How Soon Should We Feed Patients?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25409371" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Early versus on-demand nasoenteric tube feeding in acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17484894" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : AGA Institute technical review on acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17032204" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Practice guidelines in acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15667504" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21775915" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Evaluation of early enteral feeding through nasogastric and nasojejunal tube in severe acute pancreatitis: a noninferiority randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16721226" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Early enteral nutrition in severe acute pancreatitis: a prospective randomized controlled trial comparing nasojejunal and nasogastric routes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17122621" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Early nasogastric feeding in predicted severe acute pancreatitis: A clinical, randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16517959" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Nutrition support in acute pancreatitis: a systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19145726" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Systematic review: nutritional support in acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20091534" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Enteral versus parenteral nutrition for acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15175229" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21714640" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Early versus late parenteral nutrition in critically ill adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21765355" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Early use of supplemental parenteral nutrition in critically ill patients: results of an international multicenter observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19125434" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Timing and impact of infections in acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18616944" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The impact of hospital-acquired infection on outcome in acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26112745" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Pentoxifylline Treatment in Severe Acute Pancreatitis: A Pilot, Double-Blind, Placebo-Controlled, Randomized Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21731015" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Intra-abdominal fungal infections complicating acute pancreatitis: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8604829" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15097852" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17701132" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Treatment strategy against infection: clinical outcome of continuous regional arterial infusion, enteral nutrition, and surgery in severe acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18661511" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15618834" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Treatment of acute pancreatitis with protease inhibitors: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18287434" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : MDCT of acute mild (nonnecrotizing) pancreatitis: abdominal complications and fate of fluid collections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3522342" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Bacterial contamination of pancreatic necrosis. A prospective clinical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1987854" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10502187" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Endoscopic transgastric irrigation tube placement via PEG for debridement of organized pancreatic necrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12465548" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Current management of necrotizing pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15758904" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : ASGE guideline: The role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15990825" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Aggressive endoscopic therapy for pancreatic necrosis and pancreatic abscess: a new safe and effective treatment algorithm (videos).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34614330" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Immediate versus Postponed Intervention for Infected Necrotizing Pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23086243" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Interventions for necrotizing pancreatitis: summary of a multidisciplinary consensus conference.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20410514" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : A step-up approach or open necrosectomy for necrotizing pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29108721" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23587854" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Splanchnic venous thrombosis and pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15166967" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : The natural history of pancreatitis-induced splenic vein thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20624281" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Decompressive laparotomy with temporary abdominal closure versus percutaneous puncture with placement of abdominal catheter in patients with abdominal compartment syndrome during acute pancreatitis: background and design of multicenter, randomised, controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Newly diagnosed diabetes mellitus after acute pancreatitis: A systematic review and meta-analysis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8514033" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Early ductal decompression prevents the progression of biliary pancreatitis: an experimental study in the opossum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8418402" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Early treatment of acute biliary pancreatitis by endoscopic papillotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19561460" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Early endoscopic retrograde cholangiopancreatography in predicted severe acute biliary pancreatitis: a prospective multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18216529" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Early endoscopic retrograde cholangiopancreatography versus conservative management in acute biliary pancreatitis without cholangitis: a meta-analysis of randomized trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32682482" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Urgent endoscopic retrograde cholangiopancreatography with sphincterotomy versus conservative treatment in predicted severe acute gallstone pancreatitis (APEC): a multicentre randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22592743" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative management strategy in acute gallstone pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10695744" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Acute pancreatitis: management of complicating infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10556440" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Acute gallstone pancreatitis: timing of laparoscopic cholecystectomy in mild and severe disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20101174" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Early cholecystectomy safely decreases hospital stay in patients with mild gallstone pancreatitis: a randomized prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26460661" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27793575" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Unrecognized necrosis at same admission cholecystectomy for pancreatitis increases organ failure and infected necrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15571590" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Recurrence of acute gallstone pancreatitis and relationship with cholecystectomy or endoscopic sphincterotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12004991" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Role of magnetic resonance cholangiopancreatography in patients with suspected choledocholithiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1955135" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Occult microlithiasis in 'idiopathic' acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1734248" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Biliary sludge as a cause of acute pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26583660" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Can Laparoscopic Cholecystectomy Prevent Recurrent Idiopathic Acute Pancreatitis?: A Prospective Randomized Multicenter Trial.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
